Form 4 Filing for Frank Zavrl - Stock Option Grant

On June 8, 2026, Frank Zavrl, a director at CervoMed Inc., was granted a stock option to purchase 8,150 shares of the company's common stock. This grant, awarded under the 2025 Equity Incentive Plan, is part of the non-employee director compensation policy. The option has an exercise price of $2.91 and an expiration date of June 8, 2036. The shares will vest monthly over one year, starting June 30, 2026, contingent upon continued service. This transaction is reported on Form 4, with the signature dated June 10, 2026.